Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trang T Ly

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
JAMA|September 26, 2013
Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trialTrang T Ly, Jennifer A Nicholas, Adam Retterath, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2023
Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management SystemGrazia Aleppo, Daniel J DeSalvo, Felipe Lauand, et al.
Diabetes Care|December 17, 2020
Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin InfusionSarah M McGaugh, Dessi P Zaharieva, Rubin Pooni, et al.
Journal of Diabetes Science and Technology|September 19, 2014
The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetesMatthew Stenerson, Fraser Cameron, Shelby R Payne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetesTrang T Ly, Alan J M Brnabic, Andrew Eggleston, et al.
Journal of Diabetes Science and Technology|September 14, 2016
Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 DiabetesMarzia Cescon, Daniel J DeSalvo, Trang T Ly, et al.
Pediatric Diabetes|April 30, 2016
In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetesLaurel H Messer, Peter Calhoun, Bruce Buckingham, et al.
Diabetes, Obesity & Metabolism|October 9, 2024
Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery SystemGeorgia M Davis, Anne L Peters, Bruce W Bode, et al.
Diabetes Care|February 14, 2023
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop TherapyGeorgia M Davis, Anne L Peters, Bruce W Bode, et al.
Sensors (Basel, Switzerland)|January 19, 2017
Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)Daniel P Howsmon, Faye Cameron, Nihat Baysal, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
JAMA|September 26, 2013
Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trialTrang T Ly, Jennifer A Nicholas, Adam Retterath, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2023
Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management SystemGrazia Aleppo, Daniel J DeSalvo, Felipe Lauand, et al.
Diabetes Care|December 17, 2020
Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin InfusionSarah M McGaugh, Dessi P Zaharieva, Rubin Pooni, et al.
Journal of Diabetes Science and Technology|September 19, 2014
The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetesMatthew Stenerson, Fraser Cameron, Shelby R Payne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetesTrang T Ly, Alan J M Brnabic, Andrew Eggleston, et al.
Journal of Diabetes Science and Technology|September 14, 2016
Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 DiabetesMarzia Cescon, Daniel J DeSalvo, Trang T Ly, et al.
Pediatric Diabetes|April 30, 2016
In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetesLaurel H Messer, Peter Calhoun, Bruce Buckingham, et al.
Diabetes, Obesity & Metabolism|October 9, 2024
Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery SystemGeorgia M Davis, Anne L Peters, Bruce W Bode, et al.
Diabetes Care|February 14, 2023
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop TherapyGeorgia M Davis, Anne L Peters, Bruce W Bode, et al.
Sensors (Basel, Switzerland)|January 19, 2017
Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)Daniel P Howsmon, Faye Cameron, Nihat Baysal, et al.
Pageof 7